Abstract
Invasive fungal infections, particularly those caused by Candida species, are not uncommon in critically ill patients and are associated with considerable morbidity and mortality. Diagnosis and management of these infections can be challenging. In this review, we will briefly discuss recent epidemiological data on invasive candidiasis and current diagnostic approaches before concentrating on antifungal treatments.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 125-130 |
Numero di pagine | 6 |
Rivista | Critical Care |
Volume | 20 |
Numero di pubblicazione | 1 |
DOI | |
Stato di pubblicazione | Pubblicato - 2016 |
All Science Journal Classification (ASJC) codes
- Terapia Intensiva e Rianimazione
Keywords
- Antifungal Agents
- Candida albicans
- Candidiasis
- Critical Care and Intensive Care Medicine
- Disease Management
- Fluconazole
- Humans
- Intensive Care Units
- Triazoles